Business Context and Reporting Period
Company: Novo Nordisk A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 22, 2026
Context: This filing reports on the execution of a share repurchase programme initiated on May 6, 2026, under the EU Market Abuse Regulation (MAR) Safe Harbour Rules. Novo Nordisk is a global healthcare company focused on defeating serious chronic diseases, employing approximately 68,800 people across 80 countries.
Key Financial Metrics and Share Repurchase Activity
Share Repurchase Programme Details:
- Total Programme Cap: Up to DKK 15 billion over a 12-month period beginning February 4, 2026.
- Specific Tranche (May 6, 2026): Up to DKK 11,200,000,010.45 for B shares between May 6, 2026, and February 1, 2027.
- Transactions Reported (June 15–19, 2026):
- June 15: 225,000 shares @ DKK 286.10 (Value: DKK 64,371,831)
- June 16: 220,000 shares @ DKK 283.38 (Value: DKK 62,343,589)
- June 17: 220,000 shares @ DKK 288.00 (Value: DKK 63,360,172)
- June 18: 220,000 shares @ DKK 282.33 (Value: DKK 62,113,147)
- June 19: 190,000 shares @ DKK 293.48 (Value: DKK 55,760,610)
- Accumulated under May 6 Programme: 6,200,000 B shares for a total value of DKK 1,777,005,178.
- Total Repurchased since Feb 4, 2026: 20,959,179 B shares at an average price of DKK 266.09, totaling DKK 5,577,005,168.
Treasury Shares: Novo Nordisk holds 38,144,480 B shares as treasury shares, representing 0.9% of the total share capital (4,465,000,000 shares including treasury shares).
Other Financial Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes
The primary material change reported is the reduction of outstanding shares through the active execution of the share buyback programme. Since the last announcement on June 15, 2026, the company repurchased an additional 1,075,000 B shares. The total treasury share count has increased to 38,144,480 shares.
Guidance, Outlook, and Risks
Outlook: Management expects to continue repurchasing B shares up to the DKK 15 billion limit during the 12-month period starting February 4, 2026. As of June 19, 2026, approximately DKK 5.58 billion of the DKK 15 billion programme has been utilized.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard execution of the repurchase programme under regulatory safe harbour rules.
Key Facts for Investor Verification
- Verify the remaining capacity of the DKK 15 billion share repurchase programme (approx. DKK 9.42 billion remaining as of June 19, 2026).
- Confirm the impact of the 0.9% treasury share holding on earnings per share (EPS) calculations in upcoming financial reports.
- Monitor the average purchase price trend (currently DKK 266.09 overall, with recent trades ranging between DKK 282 and DKK 293) against market price fluctuations.
- Check the company website (novonordisk.com) for daily transaction details as required by the filing.